| Type |
Details |
Score |
| Publication |
| First Author: |
Allen-Petersen BL |
| Year: |
2014 |
| Journal: |
Oncogene |
| Title: |
Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer. |
| Volume: |
33 |
| Issue: |
10 |
| Pages: |
1306-15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Castillo-Lluva S |
| Year: |
2015 |
| Journal: |
Oncogene |
| Title: |
A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development. |
| Volume: |
34 |
| Issue: |
36 |
| Pages: |
4777-90 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Deng X |
| Year: |
2012 |
| Journal: |
Neoplasia |
| Title: |
Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. |
| Volume: |
14 |
| Issue: |
8 |
| Pages: |
678-89 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Volker SE |
| Year: |
2018 |
| Journal: |
Cancer Res |
| Title: |
Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland. |
| Volume: |
78 |
| Issue: |
14 |
| Pages: |
3877-3887 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yen L |
| Year: |
2006 |
| Journal: |
Cancer Res |
| Title: |
Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. |
| Volume: |
66 |
| Issue: |
23 |
| Pages: |
11279-86 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rao GN |
| Year: |
1999 |
| Journal: |
Breast Cancer Res Treat |
| Title: |
Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene. |
| Volume: |
58 |
| Issue: |
3 |
| Pages: |
241-54 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Allele |
| Name: |
erb-b2 receptor tyrosine kinase 2; targeted mutation 3, William Muller |
| Allele Type: |
Targeted |
| Attribute String: |
Conditional ready, Inserted expressed sequence |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Diévart A |
| Year: |
1999 |
| Journal: |
Oncogene |
| Title: |
Involvement of Notch1 in the development of mouse mammary tumors. |
| Volume: |
18 |
| Issue: |
44 |
| Pages: |
5973-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cool M |
| Year: |
1999 |
| Journal: |
Cancer Res |
| Title: |
Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice. |
| Volume: |
59 |
| Issue: |
10 |
| Pages: |
2438-44 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cool M |
| Year: |
2006 |
| Journal: |
Genes Chromosomes Cancer |
| Title: |
Fine allelotyping of Erbb2-induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor-suppressor loci. |
| Volume: |
45 |
| Issue: |
2 |
| Pages: |
191-202 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion NF1, William Muller |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion NB1, William Muller |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, John DiGiovanni |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
erb-b2 receptor tyrosine kinase 2; targeted mutation 4, William J Muller |
| Allele Type: |
Targeted |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
erb-b2 receptor tyrosine kinase 2; targeted mutation 5, William J Muller |
| Allele Type: |
Targeted |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
erb-b2 receptor tyrosine kinase 2; targeted mutation 6, William J Muller |
| Allele Type: |
Targeted |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
erb-b2 receptor tyrosine kinase 2; targeted mutation 7, William J Muller |
| Allele Type: |
Targeted |
| Attribute String: |
Inserted expressed sequence, Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
PDS5 cohesin associated factor B; transgene insertion 229, Wei-Zen Wei |
| Allele Type: |
Transgenic |
| Attribute String: |
Humanized sequence, Inserted expressed sequence, Null/knockout |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, mutant strain, coisogenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tilio M |
| Year: |
2016 |
| Journal: |
Cancer Lett |
| Title: |
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib. |
| Volume: |
381 |
| Issue: |
1 |
| Pages: |
76-84 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 5, Sharon Erickson |
| Allele Type: |
Transgenic |
| Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion NN60, Philip Leder |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, Philip Leder |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, William Muller |
| Allele Type: |
Transgenic |
| Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, William Muller |
| Allele Type: |
Transgenic |
| Attribute String: |
Inducible, Inserted expressed sequence, Recombinase |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, William Muller |
| Allele Type: |
Transgenic |
| Attribute String: |
Inducible, Inserted expressed sequence, Recombinase |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Erbb2/Erbb2<+> |
| Background: |
involves: 129P2/OlaHsd |
| Zygosity: |
ht |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Erbb2/Erbb2 |
| Background: |
involves: 129P2/OlaHsd * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Erbb2/Erbb2 |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * BALB/c |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-Erbb2*,-cre)1Mul/? |
| Background: |
involves: 129S1/Sv * 129X1/SvJ * FVB/N |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-ERBB2*,-luc)6157Aami/? |
| Background: |
FVB-Tg(MMTV-ERBB2*,-luc)6157Aami |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-ERBB2*,-luc)6177Aami/? |
| Background: |
FVB-Tg(MMTV-ERBB2*,-luc)6177Aami |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-ERBB2*,-luc)6180Aami/? |
| Background: |
FVB-Tg(MMTV-ERBB2*,-luc)6180Aami |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Myh6-Erbb2)6Kaga/? |
| Background: |
involves: C57BL/6J * SJL/J |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-Erbb2)10Pjo/? |
| Background: |
involves: BALB/c * C3H * C57BL/6 |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-Erbb2)9Pjo/? |
| Background: |
involves: BALB/c * C3H * C57BL/6 |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-Erbb2)12Pjo/? |
| Background: |
involves: BALB/c * C3H * C57BL/6 |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-Erbb2)17Pjo/? |
| Background: |
involves: BALB/c * C3H * C57BL/6 |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(MMTV-Erbb2*,-cre)1Mul/? |
| Background: |
involves: FVB |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jackson-Fisher AJ |
| Year: |
2006 |
| Journal: |
Oncogene |
| Title: |
Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4. |
| Volume: |
25 |
| Issue: |
41 |
| Pages: |
5664-72 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dillon RL |
| Year: |
2009 |
| Journal: |
Cancer Res |
| Title: |
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression. |
| Volume: |
69 |
| Issue: |
12 |
| Pages: |
5057-64 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1339
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yallowitz AR |
| Year: |
2015 |
| Journal: |
Mol Cancer Res |
| Title: |
Mutant p53 Amplifies Epidermal Growth Factor Receptor Family Signaling to Promote Mammary Tumorigenesis. |
| Volume: |
13 |
| Issue: |
4 |
| Pages: |
743-54 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ghaleb A |
| Year: |
2022 |
| Journal: |
Cancer Lett |
| Title: |
Low-dose but not high-dose γ-irradiation elicits the dominant-negative effect of mutant p53 in vivo. |
| Volume: |
530 |
|
| Pages: |
128-141 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Adriance MC |
| Year: |
2004 |
| Journal: |
Oncogene |
| Title: |
Downregulation of Muc1 in MMTV-c-Neu tumors. |
| Volume: |
23 |
| Issue: |
3 |
| Pages: |
697-705 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schulz R |
| Year: |
2012 |
| Journal: |
J Exp Med |
| Title: |
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression. |
| Volume: |
209 |
| Issue: |
2 |
| Pages: |
275-89 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yuan H |
| Year: |
2018 |
| Journal: |
Oncotarget |
| Title: |
MMTV-NeuT/ATTAC mice: a new model for studying the stromal tumor microenvironment. |
| Volume: |
9 |
| Issue: |
8 |
| Pages: |
8042-8053 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xu M |
| Year: |
2022 |
| Journal: |
Commun Biol |
| Title: |
Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy. |
| Volume: |
5 |
| Issue: |
1 |
| Pages: |
1251 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
289
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
81
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
222
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
302
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
206
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
107
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Marone R |
| Year: |
2004 |
| Journal: |
Nat Cell Biol |
| Title: |
Memo mediates ErbB2-driven cell motility. |
| Volume: |
6 |
| Issue: |
6 |
| Pages: |
515-22 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zaoui K |
| Year: |
2008 |
| Journal: |
J Cell Biol |
| Title: |
Memo-RhoA-mDia1 signaling controls microtubules, the actin network, and adhesion site formation in migrating cells. |
| Volume: |
183 |
| Issue: |
3 |
| Pages: |
401-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schlatter ID |
| Year: |
2012 |
| Journal: |
PLoS One |
| Title: |
MHO1, an evolutionarily conserved gene, is synthetic lethal with PLC1; Mho1p has a role in invasive growth. |
| Volume: |
7 |
| Issue: |
3 |
| Pages: |
e32501 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sorokin AV |
| Year: |
2013 |
| Journal: |
Oncogene |
| Title: |
MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells. |
| Volume: |
32 |
| Issue: |
26 |
| Pages: |
3130-8 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
This entry is composed of Memo 1 (mediator of ErbB2-driven cell motility 1) and related proteins from eukaryotes, archaea and bacteria whose molecular function is unclear.Memo 1 is an effector of the ErbB2 receptor tyrosine kinase involved in breast carcinoma cell migration []. Its increased expression is associated with cancer aggressiveness. In breast cancer it regulates insulin-like growth factor-I receptor-dependent signaling pathway []. It binds to a specific ErbB2-derived phosphopeptide []. It regulates the localisation of the small G protein RhoA and its effector mDia1 at the plasma membrane, and thereby coordinates the organisation of the lamellipodial actin network, adhesion site formation, and MT outgrowth within the cell leading edge to sustain cell motility []. In yeast, the homologue is known as Mho1, and inhibits haploid invasive growth when overexpressed []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hirukawa A |
| Year: |
2019 |
| Journal: |
Cell Rep |
| Title: |
Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy. |
| Volume: |
29 |
| Issue: |
2 |
| Pages: |
249-257.e8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wehde BL |
| Year: |
2018 |
| Journal: |
Cell Rep |
| Title: |
Janus Kinase 1 Plays a Critical Role in Mammary Cancer Progression. |
| Volume: |
25 |
| Issue: |
8 |
| Pages: |
2192-2207.e5 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zelazny E |
| Year: |
2001 |
| Journal: |
Exp Mol Pathol |
| Title: |
Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. |
| Volume: |
70 |
| Issue: |
3 |
| Pages: |
183-93 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bulavin DV |
| Year: |
2004 |
| Journal: |
Nat Genet |
| Title: |
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. |
| Volume: |
36 |
| Issue: |
4 |
| Pages: |
343-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lahlou H |
| Year: |
2012 |
| Journal: |
Cancer Res |
| Title: |
Uncoupling of PI3K from ErbB3 impairs mammary gland development but does not impact on ErbB2-induced mammary tumorigenesis. |
| Volume: |
72 |
| Issue: |
12 |
| Pages: |
3080-90 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yang C |
| Year: |
2011 |
| Journal: |
Cancer Res |
| Title: |
The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancers. |
| Volume: |
71 |
| Issue: |
3 |
| Pages: |
937-45 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Turpin J |
| Year: |
2016 |
| Journal: |
Oncogene |
| Title: |
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. |
| Volume: |
35 |
| Issue: |
47 |
| Pages: |
6053-6064 |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1256
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1308
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
304
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
713
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
756
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
541
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
451
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
858
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gomez ML |
| Year: |
2019 |
| Journal: |
Oncogene |
| Title: |
SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation. |
| Volume: |
38 |
| Issue: |
29 |
| Pages: |
5751-5765 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sakamoto K |
| Year: |
2009 |
| Journal: |
Cancer Res |
| Title: |
Targeting janus kinase 2 in Her2/neu-expressing mammary cancer: Implications for cancer prevention and therapy. |
| Volume: |
69 |
| Issue: |
16 |
| Pages: |
6642-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wallace JA |
| Year: |
2013 |
| Journal: |
PLoS One |
| Title: |
Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer. |
| Volume: |
8 |
| Issue: |
8 |
| Pages: |
e71533 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 202, William Muller |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Takeuchi N |
| Year: |
2004 |
| Journal: |
Cancer Res |
| Title: |
Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice. |
| Volume: |
64 |
| Issue: |
20 |
| Pages: |
7588-95 |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion NK1, William Muller |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, Lewis A Chodosh |
| Allele Type: |
Transgenic |
| Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Morrison Joly M |
| Year: |
2016 |
| Journal: |
Cancer Res |
| Title: |
Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers. |
| Volume: |
76 |
| Issue: |
16 |
| Pages: |
4752-64 |
|
•
•
•
•
•
|
| Allele |
| Name: |
erb-b2 receptor tyrosine kinase 2; targeted mutation 8.1, William J Muller |
| Allele Type: |
Targeted |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Citron F |
| Year: |
2020 |
| Journal: |
Cancer Res |
| Title: |
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer. |
| Volume: |
80 |
| Issue: |
5 |
| Pages: |
1064-1077 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
congenic, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Piechocki MP |
| Year: |
2003 |
| Journal: |
J Immunol |
| Title: |
Human ErbB-2 (Her-2) transgenic mice: a model system for testing Her-2 based vaccines. |
| Volume: |
171 |
| Issue: |
11 |
| Pages: |
5787-94 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yong CS |
| Year: |
2015 |
| Journal: |
PLoS One |
| Title: |
Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene. |
| Volume: |
10 |
| Issue: |
9 |
| Pages: |
e0136817 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Radkevich-Brown O |
| Year: |
2009 |
| Journal: |
Cancer Res |
| Title: |
Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice. |
| Volume: |
69 |
| Issue: |
1 |
| Pages: |
212-8 |
|
•
•
•
•
•
|